ArticleEBioMedicine2024

Genomic profiling and associated B cell lineages delineate the efficacy of neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma.

Hongyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.